title: Will atherosclerosis limit clinical xenografting?
authors.forename: K
authors.initials: K
authors.lastname: Reemtsma
authors.forename: R N
authors.initials: RN
authors.lastname: Pierson
authors.forename: C C
authors.initials: CC
authors.lastname: Marboe
authors.forename: R E
authors.initials: RE
authors.lastname: Michler
authors.forename: C R
authors.initials: CR
authors.lastname: Smith
authors.forename: E A
authors.initials: EA
authors.lastname: Rose
authors.forename: J J
authors.initials: JJ
authors.lastname: Fenoglio
mesh_terms: D000818:Animals; D001158:Arteries / Q000473:pathology; D001161:Arteriosclerosis / Q000209:etiology* / Q000473:pathology; D003327:Coronary Disease / Q000209:etiology / Q000473:pathology; D006085:Graft Survival; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000098:blood supply; D016030:Kidney Transplantation; D008252:Macaca fascicularis; D010215:Papio; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000009:adverse effects*; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents